drugset / Trial / NCT03400241

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

NCT03400241

Phase 1 Completed 24 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

Absorption of inhaled tiotropium is compared between three Tiotropium Easyhaler products and Spiriva capsules inhaled via HandiHaler. All subjects will receive all products as a single dose.

Timeline

Start
2018-02-19
Primary completion
2018-04-18
Completion
2018-04-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tiotropium Other / unclassified 10 ug Inhaled
Comparator Tiotropium Other / unclassified 18 ug Inhaled

Indications

No indication recorded.